APA

Luo Y., Lai X., Tan Y., Shi J., Zhao Y., Han X., Zheng G., Zhu X., Sun J., Zheng Y., Wu G., He J., Chen S., Jin A., Xie W., Ye X., Cai Z., Lin M. & Huang H. (20090707). Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase. : Leukemia.

Chicago

Luo Y, Lai X-Y, Tan Y-M, Shi J-M, Zhao Y-M, Han X-Y, Zheng G-F, Zhu X-L, Sun J, Zheng Y-L, Wu G-Q, He J-S, Chen S-Y, Jin A-Y, Xie W-Z, Ye X-J, Cai Z, Lin M-F and Huang H. 20090707. Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase. : Leukemia.

Harvard

Luo Y., Lai X., Tan Y., Shi J., Zhao Y., Han X., Zheng G., Zhu X., Sun J., Zheng Y., Wu G., He J., Chen S., Jin A., Xie W., Ye X., Cai Z., Lin M. and Huang H. (20090707). Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase. : Leukemia.

MLA

Luo Y, Lai X-Y, Tan Y-M, Shi J-M, Zhao Y-M, Han X-Y, Zheng G-F, Zhu X-L, Sun J, Zheng Y-L, Wu G-Q, He J-S, Chen S-Y, Jin A-Y, Xie W-Z, Ye X-J, Cai Z, Lin M-F and Huang H. Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase. : Leukemia. 20090707.